SCHEMBL4326955

SCHEMBL4326955

Cc1ccsc1C(=O)Nc1cc(N2CCNCC2)ccc1C=Cc1n[nH]c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 4/20 0.58
▸ AURKB Q96GD4 4/20 0.58
▸ CHEK1 O14757 3/20 0.43
▸ FLT3 P36888 3/20 0.43
▸ PLK4 O00444 2/20 0.43
▸ FGFR1 P11362 2/20 0.43
▸ FLT1 P17948 2/20 0.43
▸ BMPR1B O00238 1/20 0.43
▸ STK25 O00506 1/20 0.43
▸ CIT O14578 1/20 0.43
▸ RIOK3 O14730 1/20 0.43
▸ IKBKB O14920 1/20 0.43
▸ GAK O14976 1/20 0.43
▸ DCLK1 O15075 1/20 0.43
▸ CHUK O15111 1/20 0.43
▸ MUSK O15146 1/20 0.43
▸ EPHB6 O15197 1/20 0.43
▸ PDPK1 O15530 1/20 0.43
▸ MAP3K13 O43283 1/20 0.43
▸ DAPK3 O43293 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4326949 1.00 AURKA (0.58) AURKAAURKBCHEK1FLT3PLK4
SCHEMBL4314913 0.93 AURKA (0.58) AURKAAURKBFLT3FGFR1FLT1
SCHEMBL4314905 0.93 AURKA (0.58) AURKAAURKBFLT3FGFR1FLT1
Hydrochloric Acid SCHEMBL4322749 0.91 AURKA (0.56) AURKAAURKBFLT3FGFR1FLT1
SCHEMBL4320741 0.91 AURKA (0.60) AURKAAURKBCHEK1FLT3PLK4
SCHEMBL4320733 0.91 AURKA (0.60) AURKAAURKBCHEK1FLT3PLK4
Hydrochloric Acid SCHEMBL4322744 0.91 AURKA (0.56) AURKAAURKBFLT3FGFR1FLT1
SCHEMBL5265469 0.91 AURKA (0.60) AURKAAURKBCHEK1FLT3PLK4
SCHEMBL4313589 0.89 AURKA (0.60) AURKAAURKBFGFR1FLT1INSR
SCHEMBL4313585 0.89 AURKA (0.60) AURKAAURKBFGFR1FLT1INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 AURKA 3687/4885AURKB 3438/4885CHEK1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback